Long-Term Prognosis of Suspected Myocarditis and Cardiomyopathy Associated with Viral Infection of the Myocardial Tissue: A Meta-Analysis of Cohort Studies
Table 2
Baseline data for studies included in meta-analysis.
Study
Arrhythmia∆
Echocardiography
Cardiac index (L/min/m2)
Heart failure duration (months)
New York Heart Association (NYHA)
LVEF (%)
LVEDD (mm)
LVEDP (mm Hg)
I
II
III
IV
Why, H. J. F. et al. 1994
Virus+: 8
Virus+: 38.9 ± 18.0
-
Virus+: 18.2 ± 9.8
-
Virus+: 7.8 ± 9.6
Virus+: 0
Virus+: 9
Virus+: 16
Virus+: 16
Virus−: 22
Virus−: 36.2 ± 17.0
Virus−: 19.9 ± 10.0
Virus−: 14.9 ± 19.0
Virus−: 1
Virus−: 21
Virus−: 33
Virus−: 24
Figulla, H. R. et al. 1995
Virus+: 7
Virus+: 35
Virus+: 66
-
-
25
Virus+: 20
Virus+: 45
Virus+: 30
Virus+: 5
Virus−: 8
Virus−: 34
Virus−: 64
Virus−: 16
Virus−: 47
Virus−: 35
Virus−: 2
Fujioka, S. et al. 2000
-
Virus+: 17.8 ± 6.6
Virus+: 80.4±7.9
-
-
-
0
0
Virus+: 2
Virus+: 7
Virus−: 18.4 ± 7.4
Virus−: 79.9 ± 11.1
Virus−: 5
Virus−: 12
Caforio, A. L. P. et al. 2007
22
Virus+:38 ± 14
-
12
Virus+: 2.9
80
27
56
11
Virus−: 45 ± 14
Virus−: 3.2
Kindermann, I. et al. 2008
-
37.7 ± 18.5
36.2 ± 6.90
15.6 ± 7.40
-
-
39
52
73
17
Nowalany-Kozielska, E. et al. 2016
5
Virus+: 36.3 ± 14.7
Virus+: 59.6 ± 12.9
-
19.2 ± 6.4
Average NYHA:
Virus−: 37.2 ± 12.2
Virus−: 57.9 ± 11.1
Virus+: 1.9 ± 0.8
Virus−: 2.0 ± 0.8
Tebbe, U. et al. 2016
-
50
-
-
-
-
-
-
-
-
Karatolios, K. et al. 2017
-
29.2 ± 8.5
70.1 ± 9.2
19.2 ± 8.8
-
-
4
23
25
3
Kuethe, F. et al. 2017
-
33.3 ± 13.5
63.6 ± 9.0
20.9 ± 9.2
2.1 ± 0.8
-
48
15
125
30
Hjalmarsson, C. et al. 2019
-
Virus+: 27 ± 13
-
-
Virus+: 2.3 ± 0.86
Virus+: 31 ± 15
Virus+: 3
Virus+: 9
Virus+: 10
Virus+: 7
Virus−: 26 ± 12
Virus−: 2.0 ± 0.49
Virus−: 7 ± 8
Virus−: 0
Virus−: 4
Virus−: 5
Virus−: 2
∆: Atrial fibrillation and arrhythmia of nonsinus rhythm, LVEF: left ventricular ejection fraction, LVEDD: left ventricular end-diastolic dimension, LVEDP: left ventricular end-diastolic pressure.
